Parkinson's Disease (PD) is a neurodegenerative disease that progressively takes away a person’s ability to walk. In the U.S., there are over 1 million people with PD and more than 60,000 people diagnosed with the disease each year. Based on previous research conducted at University of Delaware Parkinson's Clinic, Resonate Forward, LLC (RF) has developed an untethered, vibration therapy technology that has shown improvement in the disabling gait disorders caused by PD. Resonate Forward is currently in the prototype development and clinical trial stage for this technology. Learn more about the University of Delaware Parkinson's Clinic and the Parkinson's shoe
Every person with Parkinson’s disease (PD) progresses differently but the reality is the disease progressively begins to take away functional abilities and ultimately independence. Patients tell us how the disease takes away the ability to write, talk clearly, the ability to show emotion, and the ability to walk independently. This progression can happen very slowly over 10 years or over a few short years. People are seeking solutions to reduce symptoms and give back some independence or ability that the disease progression has taken away.
Gait disorders (walking issues) are a one of the most disabling symptoms of PD. Freezing of gait (FOG) is the most disabling symptom. FOG is described by people with PD as the feeling of their feet being stuck to the ground and not being able to take a step. FOG often results in falls and reduction of a person’s independence, activity, and quality of life. Approximately 60% of people with Parkinson's suffer with FOG.
In Parkinson's Disease the basal ganglia, the part of the brain that controls movement is damaged. The communication from the brain and nerves in your limbs is short circuited causing symptoms of shuffling, slowness, freezing, and tremor. The hypothesis we are testing is specific therapeutic vibration stimulates peripheral nerves and smoothes the communication channel to the brain. Very early research has shown promise with helping patients reduce FOG symptoms and improve gait.
Our mission at Resonate Forward is to bring this technology from the lab to commercialization to benefit patients that suffer from Parkinson's.
A healthcare innovator with experience in patient centered design, digital marketing, connected medical devices, innovative pharmaceutical packaging. Theresa has been a leader in pharmaceutical and medical device marketing and innovation for over 15 years. She has always been motivated by the challenge of developing solutions that improve life for patients and works tirelessly to find the right path to market for the Resonate Forward technology.
Dr. Pretzer-Aboff, earned both her BSN and MA from New York University, and her PhD from the University of Maryland. She is currently a professor at Virginia Commonwealth University. She has clinically worked with people with Parkinson’s disease for over 30 years. Her work in the development of interventions and vibration technology is known internationally through publications and presentations. She co-founded a multidisciplinary, telehealth Parkinson Clinic and is the co-developer of the Resonate Forward technology. She is inspired by the patients she works with everyday and finding solutions that can improve their lives and delay the impact of Parkinson's symptoms.
Dr. Bruce Chase has a B.A. from Williams College MA and a Ph.D. in Chemistry from Princeton University. He retired from DuPont in 2009 after 35 years as a senior scientist and DuPont Fellow in the Central Research Department. He was the Chair of the DuPont Fellows Forum which served as a corporate wide resource for innovation. He has worked with two previous startup companies, PAIR Technologies LLC, and Voltaic Coatings LLC. Bruce is focused on using his background in engineering and instrumentation to bring new devices to market.
John Rabolt has a B.S. in Physics and a Ph.D. in Chemical Physics. He spent 20 years at the IBM Almaden Research Center where he was a Principal Scientist. John is the founding Chair of the Department of Materials Science and Engineering at the University of Delaware, he is a leading advocate for entrepreneurship at the University of Delaware and has been part of multiple startup companies. John works directly with scientists at the University of Delaware to help transition ideas from the research lab to the market place.
Professor Scott Jones is Associate Dean in the Lerner Business School at the University of Delaware. He currently serves as Chairman of the Delaware Innovation Fund Board. Along with Dr, Chase and Professor Rabolt, he was a co-founder of PAIR Technologies LLC. Scott Works directly with students in the business school and the school of engineering to direct the transition from ideas to marketable products.
Param Sreekanth earned his BS from the National Institute of Technology, Trichy India, his MS from the University of Toledo OH and his MBA in Finance from the University of Pennsylvania Wharton School. Param has significant previous experience in DuPont spanning Ventures, Mergers & Acquisitions, and other businesses, with a focus on Venture Formation, Venture Investing, Strategy, Business Development and Finance. Param is dedicated to delivering innovative solutions in healthcare.
We hope to be conducting more research in the near future at Virginia Commonwealth University. If you would like to learn more, please reach out!
Newark, Delaware, United States